Early and intensive therapy for management of hyperglycemia and cardiovascular risk factors in patients with type 2 diabetes.
about
Insulin Aspart in the Management of Diabetes Mellitus: 15 Years of Clinical ExperienceDiabetes in older adultsDiabetes in older adults: a consensus reportMice long-term high-fat diet feeding recapitulates human cardiovascular alterations: an animal model to study the early phases of diabetic cardiomyopathyThe effect of quality of care on cardiovascular risk factors in newly diagnosed diabetic patientsEffect of intensive insulin therapy on first-phase insulin secretion in newly diagnosed type 2 diabetic patients with a family history of the disease.Gradient elution mode for the troubleshooting of matrix effect on the determination of G004 in different tissues by LC-MS/MS.Comparing the disease profiles of adult patients with type 2 diabetes mellitus attending four public health care facilities in MalaysiaAnalysis of alternatives for insulinizing patients to achieve glycemic control and avoid accompanying risks of hypoglycemiaDiabetes-related alterations in the enteric nervous system and its microenvironment.Sex differences in all-cause and cardiovascular mortality, hospitalization for individuals with and without diabetes, and patients with diabetes diagnosed early and lateRationale and design of a multicenter randomized controlled study to evaluate the preventive effect of ipragliflozin on carotid atherosclerosis: the PROTECT study.Optimizing insulin initiation in primary care: the Diabetes CoStars patient support program.Association between polymorphisms of the α-kinase 1 gene and type 2 diabetes mellitus in community-dwelling individuals.Cell based metabolic barriers to glucose diffusion: macrophages and continuous glucose monitoring.New insight into improvement of cardiovascular outcomes with intensive glycemic control in patients with metabolic syndrome and type 2 diabetes mellitus included.Rationale, Design, and Baseline Characteristics of the Utopia Trial for Preventing Diabetic Atherosclerosis Using an SGLT2 Inhibitor: A Prospective, Randomized, Open-Label, Parallel-Group Comparative Study.Evaluation of glycemic control in patients with type 2 diabetes mellitus in Chinese communities: a cross-sectional study.Potential benefit of (-)-epigallocatechin-3-gallate for macrovascular complications in diabetes.MTLRP genetic polymorphism (214C>A) was associated with Type 2 diabetes in Caucasian population: a meta-analysis.Changes of insulin resistance and β-cell function in women with gestational diabetes mellitus and normal pregnant women during mid- and late pregnant period: a case-control study.Intensification of medication and glycaemic control among patients with type 2 diabetes - the ADVANCE trial.Diabetes-Related Distress and Depressive Symptoms Are Not Merely Negative over a 3-Year Period in Malaysian Adults with Type 2 Diabetes Mellitus Receiving Regular Primary Diabetes Care.Mortality and Macrovascular Risk in Elderly With Hypertension and Diabetes: Effect of Intensive Drug Therapy.Psychological interventions for behavioral adjustments in diabetes care - a value-based approach to disease control.Attainment of recommended therapeutic targets of modifiable cardiovascular risk factors among individuals with type 2 diabetes mellitus screened at a diabetes clinic in Sri Lanka
P2860
Q28085428-5769E895-ACF8-4F2C-80AE-E7A6F1BC3C24Q30528669-426B602D-E4B7-42C2-952E-A5CF86A6C2A0Q34308751-32C2D0E5-4078-47D8-9A8F-C2467FE4CBEBQ34674362-7D6081C2-1218-4DC6-80CE-6E3E7FAFDEBCQ34761050-CF0D7C4C-D23C-4859-BF08-969C0A078603Q34795541-28C17073-BA51-447A-97C7-4C11D97BEA3DQ35174237-39C56F95-1CAA-4974-91E0-37A7F337CDF4Q35454400-B2C209EC-59AE-45FF-9A29-CB60BA590DF4Q35742163-C5B443FC-EAB2-43C7-8171-067F69AF47D2Q35988135-88FBB882-490E-4115-A7D4-92B80F7C8D03Q37106560-7664B0AB-BA8D-4877-A369-1D6E669B5306Q37251449-9A44A4CE-3714-44A1-8D67-6C4C41C399ACQ37376769-BF0B1E15-64C8-4B75-9BE7-83F5855E771DQ37565372-9C522C84-A2AC-4B12-BE7A-6322D8727A94Q37609355-4A55E30E-600F-415D-AA9E-FED920568D7BQ38239036-51CE5E9D-4EB6-4CA6-8DD5-69018B22FFC0Q38597063-8D31C3F3-022C-476B-A693-8BD5F39F5656Q40180394-90BD7607-69B2-430B-A65D-EC73DAFB16A2Q41452593-A2BD2EBE-F16B-4DDC-89DB-B2DE4704AA6EQ41916181-2FDDFE5A-80DC-4CD0-BE43-ACA0DC15F9B9Q43500277-1B1AAF76-00D2-4A89-8FC3-B9AE93FC3B19Q44004103-FAD0F1CD-250F-479F-A90B-4F8878DC9FC1Q47093510-07EDCC0C-03B4-4FBF-8C5B-D808158BA0C7Q49557238-A167D576-B66F-4CCA-9156-6498D6657096Q55001893-388D7751-0BE2-4AE9-B680-8A345505EE67Q58795647-0E25CBFC-44CD-436B-859D-866FEEF11EAA
P2860
Early and intensive therapy for management of hyperglycemia and cardiovascular risk factors in patients with type 2 diabetes.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Early and intensive therapy fo ...... patients with type 2 diabetes.
@en
Early and intensive therapy fo ...... patients with type 2 diabetes.
@nl
type
label
Early and intensive therapy fo ...... patients with type 2 diabetes.
@en
Early and intensive therapy fo ...... patients with type 2 diabetes.
@nl
prefLabel
Early and intensive therapy fo ...... patients with type 2 diabetes.
@en
Early and intensive therapy fo ...... patients with type 2 diabetes.
@nl
P921
P1476
Early and intensive therapy fo ...... patients with type 2 diabetes.
@en
P2093
George Dailey
P304
P356
10.1016/J.CLINTHERA.2011.04.025
P577
2011-06-01T00:00:00Z